Karnataka

To facilitate the increased demand for innovative application-based products, Sami Labs Limited (formerly known as Sami Chemicals & Extracts Limited) was set up in 1991 at Singasandra in Bangalore ( India ) as a research and development facility. Today the main thrust and focus of Sami is on new product development and market oriented research.

About Authors:
^*1P.SanilKumar, ¹C K. Dhanapal, ²Sandhya Ravi
¹Department of Pharmacy,
Annamali University, AnnamaliNager,
Chidambaram, Tamilnadu.
²Lotus Labs Pvt Ltd,
No.07, Jasmabhavan Road, Vasanthanager, Bangalore, Karnataka.
*sanilmpharm@gmail.com

ABSTRACT
Hospitals are created for cure the disease but not for the spreading of diseases, even though this statement is true to the theoretical concept but it is not possible practically due to various risk factors. The spread of infection in the hospitals occurs due to the microorganism. Nosocomial infections add significantly to the economic burden of managing the underlying disease that has lead to hospitalization of the patient. More than 90% of reported infections are bacterial where as viral, fungal or protozoal infections are less commonly involved in hospital-acquired infections. This project deals with bacterial nosocomial pathogens only, since they are by far major causes of nosocomial infections. Objective of the present study include  the identification, prevention and control of nosocomial infection in our hospitals. The ultimate aim is the reduction of nosocomial infections and their costs. Baseline study for morbidity pattern in the hospitals, finding sources of exogenous and endogenous sources of nosocomial infection. Suggest measures to minimize the nosocomial infections and suggest guidelines for efficacious management of nosocomial infections.

[adsense:336x280:8701650588]

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country.
Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.

Ajanta Pharma Limited is an emerging, global pharmaceutical company with proven capabilities in the areas of product research, manufacturing & marketing.

Syngene International is one of India’s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area.

Applications are invited for purely temporary posts at Regional Medical Research Centre (ICMR), Belgaum under ad hoc project entitled "Documentation of genetic and phytochemical variation and assessement of immunomodulatory and anticancer activities of Gymnema sylvestre (Retz) R.BR & S and newly described species Gymnema kollimalayanum Ramach & M.B. Viswan, From Eastern India and Western Ghats"

St. Martha’s Hospital is owned and managed by the Sisters of the Good Shepherd.  The hospital was started with just 50 beds in the land that was given by Sri Chamaraja Wodeyar X, the then Maharaja of Mysore in the year 1884.  In the year 1884 the Rt. Revd. Monsignor Bishop Charbonnaux M.E.P., Archbishop of Bangalore, invited the Sisters to the Archdiocese to establish and open schools and orphanages for young girls to be treated with kindness and dignity.